Zhejiang Tianyu Pharmaceutical (300702.SZ): US FDA issues warning letter to the company's production site in Huangyan River.

Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that the company has received a notification letter from the US FDA regarding the closure of a warning letter. The letter informs the company that the FDA has completed an evaluation of the corrective actions taken in response to the warning letter (number 320-22-23) issued on August 17, 2022. Based on the evaluation results, the FDA believes that the company has effectively addressed the deviations mentioned in the warning letter.